ReviewHeart failure reviews2025

Myeloperoxidase inhibition in the landscape of anti-inflammatory therapies for heart failure with preserved ejection fraction: the ENDEAVOR trial.

Veraprapas Kittipibul et al.PubMed ↗Publisher ↗

No numbers read from the abstract.